Related Experiment Video
Updated: Jan 9, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell
Ye Zhang1, Lydie Debaize2, Adam Langenbucher3
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Insights
Single-cell biophysical properties like buoyant mass and stiffness can identify cancer cell phenotypes. These properties correlate with treatment response, offering new biomarkers for precision medicine in B cell malignancies.
Area of Science:
- Biophysics
- Oncology
- Cell Biology
Background:
- Intratumor heterogeneity complicates cancer progression and treatment resistance.
- Conventional methods struggle to fully characterize cellular diversity.
- Single-cell biophysical properties offer complementary insights into functional phenotypes.
Purpose of the Study:
- To link single-cell biophysical properties (buoyant mass, stiffness) to gene expression in mantle cell lymphoma (MCL).
- To identify clinically relevant phenotypes within MCL cells.
- To explore the potential of biophysical properties as biomarkers for therapeutic response.
Main Methods:
- Linked measurements of buoyant mass, stiffness, and gene expression in MCL cells.
- Analysis of primary patient specimens ex vivo.
- Correlation of biophysical properties with sensitivity to Bruton's tyrosine kinase inhibitors.
Main Results:
- Buoyant mass and stiffness characterize B cell development states and correlate with oncogenic signaling genes (e.g., BLK, CD79A).
- Changes in cell buoyant mass in patient samples correlate with ex vivo sensitivity to Bruton's tyrosine kinase inhibitors.
- These biophysical properties are relevant in both mantle cell lymphoma and chronic lymphocytic leukemia.
Conclusions:
- Single-cell biophysical properties provide valuable biomarkers for understanding cancer heterogeneity.
- Buoyant mass and stiffness can predict response to targeted therapies like Bruton's tyrosine kinase inhibitors.
- Biophysical profiling holds promise for advancing precision therapeutic strategies in B cell malignancies.
Abstract:
Intratumor heterogeneity impacts disease progression and therapeutic resistance but remains poorly characterized by conventional histologic, immunophenotypic, and molecular approaches. Single-cell biophysical properties distinguish functional phenotypes complementary to these approaches, providing additional insight into cellular diversity. Here, we link both buoyant mass and stiffness to gene expression to identify clinically relevant phenotypes within primary mantle cell lymphoma (MCL) cells, using MCL as a model of biological and clinical diversity in human cancer. Linked measurements reveal that buoyant mass and stiffness characterize B cell development states from naïve to plasma cell and correlate with expression of oncogenic B cell receptor signaling genes such as BLK and CD79A. In addition, changes in cell buoyant mass within primary patient specimens ex vivo correlate with sensitivity to Bruton's tyrosine kinase inhibitors in vivo in MCL and chronic lymphocytic leukemia, another B cell malignancy. These findings highlight the value of biophysical properties as biomarkers of response in pursuit of future precision therapeutic strategies.
More Related Videos
10:23Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations
Published on: January 19, 2017
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018